We have generated TRPML1 KO SK-MEL-5 melanoma cells in addition to previously generated KOs for Rab7a and TPC2 in SK-MEL-5 cells [30] using CRISPR/Cas9. This evidence concerns the gene TPCN2 and melanoma.